223 related articles for article (PubMed ID: 23357690)
1. [Myeloproliferative neoplasms related glomerulopathy].
Paule R; Ponsoye M; Gueutin V; Deray G; Izzedine H
Rev Med Interne; 2013 Jun; 34(6):369-72. PubMed ID: 23357690
[TBL] [Abstract][Full Text] [Related]
2. Myeloproliferative neoplasms cause glomerulopathy.
Said SM; Leung N; Sethi S; Cornell LD; Fidler ME; Grande JP; Herrmann S; Tefferi A; D'Agati VD; Nasr SH
Kidney Int; 2011 Oct; 80(7):753-9. PubMed ID: 21654720
[TBL] [Abstract][Full Text] [Related]
3. [The myeloproliferative neoplasms-related glomerulopathy].
Bardy A; Tiple A; Rabant M; Kémény JL; El Karoui K; Hermet M; Guettrot-Imbert G; Deteix P; Bay JO; Aumaître O; André M
Rev Med Interne; 2014 Apr; 35(4):222-30. PubMed ID: 23743480
[TBL] [Abstract][Full Text] [Related]
4. Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms.
Büttner-Herold M; Sticht C; Wiech T; Porubsky S
Histopathology; 2021 Apr; 78(5):738-748. PubMed ID: 33078472
[TBL] [Abstract][Full Text] [Related]
5. Novel Detection of CALR-Mutated Cells in Myeloproliferative Neoplasm-Related Glomerulopathy With Interstitial Extramedullary Hematopoiesis: A Case Report.
Maruyama K; Nakagawa N; Suzuki A; Kabara M; Matsuki M; Shindo M; Iwasaki S; Ogawa Y; Hasebe N
Am J Kidney Dis; 2019 Dec; 74(6):844-848. PubMed ID: 31377025
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms.
Rungjirajittranon T; Owattanapanich W; Ungprasert P; Siritanaratkul N; Ruchutrakool T
BMC Cancer; 2019 Feb; 19(1):184. PubMed ID: 30819138
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology of myeloproliferative neoplasms.
Klco JM; Vij R; Kreisel FH; Hassan A; Frater JL
Am J Clin Pathol; 2010 Apr; 133(4):602-15. PubMed ID: 20231614
[TBL] [Abstract][Full Text] [Related]
8. Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.
Person F; Meyer SC; Hopfer H; Menter T
Virchows Arch; 2021 Nov; 479(5):1013-1020. PubMed ID: 34164707
[TBL] [Abstract][Full Text] [Related]
9. Renal disease associated with chronic myeloproliferative neoplasms.
Lucijanic M; Krecak I; Kusec R
Expert Rev Hematol; 2022 Feb; 15(2):93-96. PubMed ID: 35125041
[No Abstract] [Full Text] [Related]
10. Advances in understanding and management of myeloproliferative neoplasms.
Vannucchi AM; Guglielmelli P; Tefferi A
CA Cancer J Clin; 2009; 59(3):171-91. PubMed ID: 19369682
[TBL] [Abstract][Full Text] [Related]
11. Myeloproliferative Neoplasm and Myelodysplastic Syndrome-Associated Renal Disease: A Histopathological Report of Two Cases.
Popov H; Koleva T; Stoyanov GS; Ghenev P
Cureus; 2022 Dec; 14(12):e32388. PubMed ID: 36632253
[TBL] [Abstract][Full Text] [Related]
12. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of myeloproliferative neoplasm and plasma-cell dyscrasia.
Malhotra J; Kremyanskaya M; Schorr E; Hoffman R; Mascarenhas J
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):31-6. PubMed ID: 24220620
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and Management of Thrombotic Disease in Myeloproliferative Neoplasms.
Arachchillage DR; Laffan M
Semin Thromb Hemost; 2019 Sep; 45(6):604-611. PubMed ID: 31382304
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and management of acute myeloid leukemia that has evolved from a myeloproliferative neoplasm.
Rampal R; Mascarenhas J
Curr Opin Hematol; 2014 Mar; 21(2):65-71. PubMed ID: 24366192
[TBL] [Abstract][Full Text] [Related]
16. Acute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative Neoplasms.
Czader M; Orazi A
Am J Clin Pathol; 2015 Aug; 144(2):188-206. PubMed ID: 26185305
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis in myeloproliferative neoplasms.
Falanga A; Marchetti M
Semin Thromb Hemost; 2014 Apr; 40(3):348-58. PubMed ID: 24610470
[TBL] [Abstract][Full Text] [Related]
18. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.
Tefferi A; Vardiman JW
Leukemia; 2008 Jan; 22(1):14-22. PubMed ID: 17882280
[TBL] [Abstract][Full Text] [Related]
19. Secondary acute myeloid leukemias arising from Philadelphia chromosome negative myeloproliferative neoplasms: pathogenesis, risk factors, and therapeutic strategies.
Tallarico M; Odenike O
Curr Hematol Malig Rep; 2015 Jun; 10(2):112-7. PubMed ID: 25893311
[TBL] [Abstract][Full Text] [Related]
20. Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis.
Pettersson H; Knutsen H; Holmberg E; Andréasson B
Eur J Haematol; 2015 Feb; 94(2):152-6. PubMed ID: 25039361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]